Author Archive for Insider Scoop

Battle Royale: Morgan Stanley Cautiously Upbeat On EA, Activision

Courtesy of Benzinga.

Battle Royale: Morgan Stanley Cautiously Upbeat On EA, Activision

A few months after the frenzied reaction to the launch of “Apex Legends” by Electronic Arts Inc. (NASDAQ: EA), attention is turning to whether interest will continue in the game that EA hopes will challenge “Fortnite” for supremacy in the battle royale arena.

“Call of Duty” from Activision Blizzard Inc. (NASDAQ: ATVI) is going mobile, giving the company added opportunity in the fastest-growing games segment — and likely helping boost its stock Tuesday.

Morgan Stanley kept ratings on the two gaming stocks unchanged, but reminded investors of positives worth watching at both companies.

The Analyst

Morgan Stanley’s Brian Nowak maintained an Equal-Weight rating on EA and raised the price target from $80 to $88.

Nowak maintained an Overweight rating on Activision Blizzard with a $55 price target.

The Thesis 

EA drew tons of attention and investor excitement in February when it launched the multiplayer shooter game “Apex Legends,” quickly hitting 50 million players and driving EA stock up as observers predicted that “Fortnite” would no longer be the only game in town.

The huge number of “Apex” players in the first month; high review scores; and the arrival Tuesday of EA’s newest perceived money-making opportunity around “Apex,” a season pass, led Nowak to boost the price estimate.

Morgan Stanley is raising its fiscal 2020 earnings per share estimates for EA by 8 percent, with $375 million in live services revenue coming from “Apex.”

Nowak also reminded investors not to lose sight of EA’s legacy games in the “FIFA” and “Star Wars” franchises, which he estimates will still drive 55 percent of 2020 earnings per share.

Nowak said he remains “tactically cautious” because of volatility in the stock price and has questions about long-term continued success.

“Ultimately, the game’s ability to drive sustained engagement is still unproven, despite early success, and we expect the topic to remain a battleground until the financial impact is more visible.”

Call Of Duty

The launch of “Call of Duty” mobile is important to ATVI as it tries to capitalize on its leading position in intellectual property in the growing free and mobile gaming markets, Nowak said.

Mobile gaming, at $85 billion, is the largest and fastest growing category in the gaming space, the analyst said.

If a “Call of


continue reading





Sage’s First-Of-Its-Kind Postpartum Depression Drug Clears FDA Hurdle: What You Need to Know

Courtesy of Benzinga.

Sage's First-Of-Its-Kind Postpartum Depression Drug Clears FDA Hurdle: What You Need to Know

Shares of mid-cap biotech SAGE Therapeutics Inc (NASDAQ: SAGE), which focuses on therapies for central nervous system disorders, were trading higher Wednesday.

What Happened

Sage said the FDA approved its Zulresso — chemically brexanolone — an injection for the treatment of postpartum depression.

With the approval, Zulresso becomes the first and only medicine specifically approved for treating postpartum depression, or PPD, Sage said in a Tuesday evening press release. 

The approval required an in-line label that included a REMS program for the drug to be administered at certified sites.

Zulresso has both Priority Review status as well as a Breakthrough Therapy Designation from the FDA.

The FDA nod was based on findings from three multicenter, double-blind, placebo-controlled trials that evaluated Zulresso in women with moderate and severe PPD ages 18-45. 

Why It’s Important

PPD, according to the company, is the most common medical complication of childbirth, estimated to affect about 400,000 women annually in the U.S.

“The potential to rapidly reduce symptoms in this critical disorder is an exciting milestone in women’s mental health,” said Samantha Meltzer, the primary investigator of the Zulresso clinical trials.

“PPD is recognized to have a significant and long-term impact on women and their families, but with Zulresso we may finally have the opportunity to change that.”

The Zulresso approval is a key box check as Sage builds out its commercial sales capacity, RBC Capital Markets analyst Brian Abrahams said in a Tuesday note.

That said, the drug is unlikely to contribute meaningfully to revenue in 2019 in light of the remaining steps required for the launch, including DEA signing, site certifications and reimbursement, the analyst said.

Abrahams estimates a $13-million contribution from Zulresso in 2019, with potential for upside from incrementally favorable pricing, and about a 12-percent contribution to valuation.

RBC estimates peak Zulresso sales are at $370 million.

Abrahams sees Sage’s late-stage asset SAGE-217, which is being evaluated for major depressive disorder, as more important for Sage than Zulresso, given the former’s peak opportunity of over $3.5 billion.

What’s Next

Sage said the drug will be available in late June following scheduling by the DEA, which is expected to occur within 90 days.

“We continue to be buyers on what we view as significantly underappreciated $4-billion annual


continue reading





What Is The Value Of The FOMC Minutes?

Courtesy of Benzinga.

What Is The Value Of The FOMC Minutes?

The Federal Reserve Open Market Committee will be publicly releasing the minutes from its latest meeting this week, and the financial media is eager to report the details. But just how important for traders are the minutes from a meeting that took place weeks ago?

What Are FOMC Minutes?

The FOMC periodically meets to discuss policy decisions, and it typically releases the official details from this meetings roughly two weeks later. The FOMC meetings are typically seen by traders as a potential market catalyst, especially if the Federal Reserve changes direction or hints at future actions regarding interest rates.

The stock market and other financial markets price in expected Fed action prior to the release of the minutes. On the rare occasion the minutes reveal more dovish or hawkish policy discussions that investors anticipated, the result can be volatile trading action.

The last time investors got a glimpse behind the scenes of the Fed meeting, the FOMC minutes revealed that the Fed discussed dialing back its 2017 plan to shrink its $4-trillion balance sheet, a potentially dovish move. Fed members said they are willing to be “patient” on further interest rate hikes despite “solid” U.S. economic growth numbers. Relatively stable consumer price index growth of around 2 percent suggests the economy is not in immediate danger of overheating.

Should Investors Care?

Shawn Cruz, senior trading specialist at TD Ameritrade, told Benzinga that the Fed minutes give investors important hints about where they should focus their attention.

“When they start talking about areas where they are concerned with, it can help guide you with what economic data you should be focused on,” he said. 

“So if they are talking about weakness or strength in the housing market, you’ll want to start watching housing data, because if that starts to turn, and they’re a data-driven Fed, maybe you should start to set your expectations that there could be a change in tone.”

Don’t Expect Material Information

Financial media outlets and top economists love to banter about the Fed minutes and what their implications are for the markets. Yet Owen Murray, director of investments for Horizon Advisers, told Benzinga that the typical retail investor can mostly ignore the Fed minutes.

“The announcement following their meeting usually provides the most important signals to


continue reading





A Peek Into The Markets: US Stock Futures Climb Ahead Of Fed Meeting

Courtesy of Benzinga.

A Peek Into The Markets: US Stock Futures Climb Ahead Of Fed Meeting

Pre-open movers

U.S. stock futures traded higher in early pre-market trade. The Federal Open Market Committee will begin its two-day policy meeting today. Data on factory orders for January will be released at 10:00 a.m. ET.

Futures for the Dow Jones Industrial Average climbed 103 points to 26,072.00, while the Standard & Poor’s 500 index futures gained 11 points to 2,852.00. Futures for the Nasdaq 100 index rose 27 points to 7,388.75.

Oil prices traded higher as Brent crude futures rose 0.8 percent to trade at $68.10 per barrel, while US WTI crude futures rose 0.7 percent to trade at $59.52 a barrel.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.8 percent, STOXX Europe 600 Index climbing 0.6 percent and German DAX 30 index climbed 0.8 percent. The UK’s FTSE index was trading higher by 0.4 percent, while French CAC 40 Index gained 0.4 percent.

In Asian markets, Japan’s Nikkei Stock Average fell 0.08 percent, Hong Kong’s Hang Seng Index climbed 0.19 percent, China’s Shanghai Composite Index fell 0.18 percent and India’s BSE Sensex rose 0.7 percent.

Broker Recommendation

Analysts at JP Morgan downgraded Yum! Brands, Inc. (NYSE: YUM) from Overweight to Neutral.

Yum Brands shares fell 0.62 percent to close at $100.24 on Monday.

Breaking News

  • Michaels Companies Inc (NASDAQ: MIK) reported better-than-expected results for its fourth quarter, but issued weak forecast for the first quarter.
  • Tilray Inc (NASDAQ: TLRY) reported downbeat earnings for its fourth quarter, while sales exceeded estimates. The company said total kilogram equivalents sold increased almost threefold year-over-year to 2,053 kilograms.
  • DSW Inc. (NYSE: DSW) reported downbeat earnings for its fourth quarter.
  • Aquabounty Technologies Inc (NASDAQ: AQB) reported a common stock offering. The size was not disclosed.

Posted-In: A Peek Into The Markets US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets





Analysts Mixed On Lumber Liquidators Following Q4 Earnings

Courtesy of Benzinga.

Analysts Mixed On Lumber Liquidators Following Q4 Earnings

Lumber Liquidators Holdings Inc (NYSE: LL) on Monday reported fourth-quarter results, which one analyst says brings the stock close to “becoming investible at long last.”

The Analysts

Raymond James’ Budd Bugatch maintains a Market Perform rating on Lumber Liquidators with no price target.

Morgan Stanley’s Simeon Gutman maintains at Equal-weight, price target lowered from $11 to $10.

Raymond James: ‘Becoming Investible’

Lumber Liquidators reported mixed fourth-quarter results, highlighted by a miss on the sales line and comparable store sales grew just 0.4 percent versus expectations of 2 percent. Bugatch said on the positive side, EPS of 17 cents per share (adjusting for legal costs) would have come in ahead of expectations of 14 cents per share. Management guided legal expenses to start falling in 2019.

First-quarter comps will be down by a low-single digit, but the analyst said checks so far point to a better performance so far in the quarter. The last few weeks of the first quarter could shift total comps by 1 percentage point in either direction.

The company recently settled a large legal overhang, which Bugatch said implies the stock is “becoming investible at long last.” But before buying buyers of the stock, clarity related to store operating model and what constitutes a normal corporate overhead run rate are needed.

Morgan Stanley: Struggling To Show Comp Growth

Lumber Liquidators’ report shows the company continues to struggle to drive comp growth, Gutman said. Specifically, comp growth of 0.4 percent not only fell short of expectations but merchandise comps declined 2.6 percent and decelerated by 70 basis points on a two-year stack.

Gross margins fell 40 basis points, which were worse than expectations of a five-basis point contraction. SG&A levered 70 basis points due to lower advertising costs, but the company doesn’t expect to see further declines ahead of a digital marketing push.

The EPS beat is mostly a function of the lower advertising spend, which Gutman said isn’t a sustainable driver of earnings growth.

Price Action

Shares of Lumber Liquidators traded around $9.88 at time of publication.

Related Links:

Analysts Encouraged By Lumber Liquidators Legal Process

Loop Capital Shelves Lumber Liquidators, Says Street Estimates Could Be Overly Optimistic

Photo credit: Dwight Burdette (Own work), via Wikimedia Commons


continue reading





Earnings Scheduled For March 18, 2019

Courtesy of Benzinga.

Earnings Scheduled For March 18, 2019

Companies Reporting Before The Bell

  • Lumber Liquidators Holdings, Inc. (NYSE: LL) is estimated to report quarterly earnings at $0.12 per share on revenue of $272.54 million.
  • Genesis Healthcare, Inc. (NYSE: GEN) is expected to report quarterly loss at $0.24 per share on revenue of $1.19 billion.
  • Overstock.com, Inc. (NASDAQ: OSTK) is projected to report quarterly loss at $0.91 per share on revenue of $474.15 million.
  • Qudian Inc. (NYSE: QD) is estimated to report quarterly earnings at $0.34 per share on revenue of $341.99 million.
  • Apollo Endosurgery, Inc. (NASDAQ: APEN) is expected to report quarterly loss at $0.37 per share on revenue of $14.96 million.
  • Consolidated Water Co. Ltd. (NASDAQ: CWCO) is estimated to report quarterly earnings at $0.16 per share on revenue of $15.95 million.
  • Horizon Global Corporation (NYSE: HZN) is projected to report quarterly loss at $0.66 per share on revenue of $172.10 million.
  • Novavax, Inc. (NASDAQ: NVAX) is expected to report quarterly loss at $0.12 per share on revenue of $7.09 million.
  • Teligent, Inc. (NASDAQ: TLGT) is estimated to report quarterly loss at $0.03 per share on revenue of $18.06 million.
  • Leju Holdings Limited (NYSE: LEJU) is expected to report earnings for its fourth quarter.
  • Niu Technologies (NASDAQ: NIU) is projected to report quarterly earnings at $0.01 per share on revenue of $57.39 million.
  • Viomi Technology Co., Ltd (NASDAQ: VIOT) is estimated to report quarterly earnings at $0.1 per share on revenue of $129.44 million.
  • GP Strategies Corporation (NYSE: GPX) is expected to report quarterly earnings at $0.29 per share on revenue of $133.83 million.
  • Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is projected to report quarterly loss at $0.15 per share on revenue of $7.29 million.
  • Protalix BioTherapeutics, Inc. (NYSE: PLX) is expected to report quarterly loss at $0.05 per share on revenue of $10.45 million.

Companies Reporting After The Bell

  • PFSweb, Inc. (NASDAQ: PFSW) is estimated to post quarterly earnings at $0.24 per share on revenue of $91.03 million.
  • Syneos Health, Inc. (NASDAQ:


continue reading





Needham: Facebook No Longer A Buy Amid A ‘Negative Network Effect’

Courtesy of Benzinga.

Needham: Facebook No Longer A Buy Amid A 'Negative Network Effect'

The bullish case for Facebook, Inc. (NASDAQ: FB)’s stock has come to an end, according to Needham.

The Analyst

Needham’s Laura Martin downgraded Facebook from Buy to Hold with no price target.

The Thesis

Needham’s multi-year bullish stance on Facebook’s stock can no longer be justified for three key reasons, Martin said in a research report. These include:

  1. A negative potential impact to financial metrics from the company’s recent strategic shift towards privacy and encrypted messages;
  2. Ongoing risks of regulations; and
  3. The recent terrorist attack in New Zealand makes it clear “horrific” content can’t be blocked at 100 percent.

These concerns combine to create a “negative network effect” that could serve as a means of destructing shareholder value, according to Martin. This phenomenon already resulted in 11 senior Facebook managers leaving the company, most recently Chief Product Officer Chris Cox.

Additional high-level executive departures at Facebook are likely. An ongoing turnover of important managers serves as another concern for shareholders as employing the best people is a needed competitive advantage of FAANG companies who are competing against each other to drive growth.

Bottom line, Facebook is in a weaker position to “win” if it distracted with continued management turnover and simultaneously navigating through regulatory and headline risk distractions, the analyst wrote.

Price Action

Shares of Facebook were trading lower by 2.5 percent at $161.85 Monday morning.

Related Links:

Bank Of America Lowers Facebook Price Target, Remains ‘Constructive’ On The Stock

Nomura Instinet Upgrades Facebook, Says More Regulation Will Be ‘Net Positive’

Latest Ratings for FB

Date Firm Action From To
Mar 2019 Bank of America Reiterates Buy Buy
Mar 2019 Needham Downgrades Buy Hold
Mar 2019 Nomura Upgrades Neutral Buy

View More Analyst Ratings for FB


View the Latest Analyst Ratings

Posted-In: Facebook Privacy Laura MartinAnalyst Color Short Ideas Downgrades Top Stories Analyst Ratings Trading Ideas Best of Benzinga





8 Stocks To Watch For March 15, 2019

Courtesy of Benzinga.

8 Stocks To Watch For March 15, 2019

Some of the stocks that may grab investor focus today are:

  • Wall Street expects Buckle Inc (NYSE: BKE) to report quarterly earnings at $0.85 per share on revenue of $265.46 million before the opening bell. Buckle shares fell 0.4 percent to $18.01 in after-hours trading.
  • Adobe Inc (NASDAQ: ADBE) reported stronger-than-expected results for its first quarter, but issued weak earnings outlook for the second quarter. Adobe shares fell 2.6 percent to $260.76 in the after-hours trading session.
  • Ulta Beauty Inc (NASDAQ: ULTA) reported better-than-expected earnings and sales for its fourth quarter. Ulta Beauty shares climbed 3.7 percent to $324.14 in the after-hours trading session.
  • Analysts are expecting Kirkland’s, Inc. (NASDAQ: KIRK) to have earned $1.02 per share on revenue of $216.13 million in the latest quarter. Kirkland’s will release earnings before the markets open. Kirkland’s shares fell 0.67 percent to close at $10.31 on Thursday.

Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.

Choosing the best broker is an important part of being a successful trader or investor

  • Turtle Beach Corp (NASDAQ: HEAR) reported upbeat earnings for its fourth quarter, but issued weak earnings guidance for first quarter and full year. The company also reported the purchase of PC gaming accessory business ROCCAT for $14.8 million in cash. Turtle Beach shares dropped 12.3 percent to $14.25 in the after-hours trading session.
  • Oracle Corporation (NYSE: ORCL) reported better-than-expected earnings for its third quarter. Oracle’s Board of Directors declared a quarterly cash dividend of 24 cents per share of outstanding common stock, reflecting a 26-percent increase over the current quarterly dividend of 19 cents. The company expects Q4 adjusted earnings of $1.05 to $1.09 per share. Oracle shares fell 3.2 percent to $51.38 in the after-hours trading session.
  • Analysts expect Diplomat Pharmacy, Inc. (NYSE: DPLO) to report quarterly earnings at $0.23 per share on revenue of $1.41 billion before the opening bell. Diplomat Pharmacy shares fell 0.2 percent to $6.41 in after-hours trading.
  • Zumiez Inc. (NASDAQ: ZUMZ) reported upbeat earnings for its fourth quarter, while sales missed estimates. The company issued weak guidance for the first quarter. Zumiez shares dipped 8.6 percent to $21.65 in the after-hours trading session.

Posted-In: Stocks To WatchEarnings News Pre-Market Outlook Markets Trading Ideas





Raymond James, KeyBanc Remain Dollar General Buyers After Disappointing Q4

Courtesy of Benzinga.

Raymond James, KeyBanc Remain Dollar General Buyers After Disappointing Q4

Dollar General Corp. (NYSE: DG) reported fourth-quarter results Thursday that disappointed investors, and the dollar store chain’s 2019 guidance implies heavier investments than previously expected. 

Nevertheless, two Street analysts continue recommending investors be buyers of shares of one of the largest discount retailers in the U.S. 

The Analysts

Raymond James’ Dan Wewer maintains a Strong Buy rating on Dollar General with an unchanged $127 price target.

KeyBanc Capital Markets’ Bradley Thomas maintains at Overweight, unchanged $125 price target.

Raymond James: Multiple Bullish Themes

Dollar General showed 4-percent same-store sales growth in the fourth quarter, more than twice the 1.4 percent rival Family Dollar showed within Dollar Tree, Inc. (NASDAQ: DLTR)’s earnings report, Wewer said in a Thursday note.

Dollar General’s superior same-store sales profile stems from its real estate and footprint growth, as the company added 900 new stores, remodeled 1,050 stores and relocated 115 others, the analyst said. The maturation of these projects added nearly 2 percent to same-store sales growth, he said. 

Promotional activity contributed to disappointing gross margin performance in the fourth quarter, but Dollar General said it generated “sticky relationships” that are likely to result in market share gains, Wewer said. The company should be able to gain market share in fiscal 2019 without the need to be aggressive in promotional activity, he said. 

The retailer said it will continue investing in a fresh and frozen offering and improve labor productivity in stores and warehouses, the analyst said. These initiatives will likely negatively impact profit in fiscal 2019, but become accretive in fiscal 2020, he said. 

Related Link: How Should Investors Play Dollar Tree After The Q3 Report?

KeyBanc: Long-Term Story

Dollar General’s earnings report showed an increase in average transaction size and traffic, Thomas said in a Thursday note.

Overall sales rose 8.5 percent from last year, but the operating margin fell 57 basis points to 9.6 percent and missed expectations of 10 percent, the analyst said. 

Despite a mixed fourth-quarter report and disappointing fiscal 2019 guidance, Dollar General remains one of the few retailers that offer convenience and value, Thomas said. The company’s investments in the future should put it in a position where it can drive revenue and EPS growth for the long-term, he said.

The company’s track


continue reading





Earnings Scheduled For March 14, 2019

Courtesy of Benzinga.

Earnings Scheduled For March 14, 2019

Companies Reporting Before The Bell

  • Genesco Inc. (NYSE: GCO) is projected to report quarterly earnings at $2.33 per share on revenue of $914.35 million.
  • Dollar General Corporation (NYSE: DG) is expected to report quarterly earnings at $1.88 per share on revenue of $6.60 billion.
  • Hudson Ltd. (NYSE: HUD) is estimated to report quarterly earnings at $0.15 per share on revenue of $469.01 million.
  • Uxin Limited (NASDAQ: UXIN) is expected to report quarterly loss at $0.1 per share on revenue of $158.63 million.
  • LexinFintech Holdings Ltd. (NASDAQ: LX) is estimated to report quarterly earnings at $0.23 per share on revenue of $314.26 million.
  • Sprague Resources LP (NYSE: SRLP) is projected to report quarterly earnings at $0.69 per share on revenue of $1.10 billion.
  • PPDAI Group Inc. (NYSE: PPDF) is expected to report quarterly earnings at $0.23 per share on revenue of $163.90 million.
  • RadNet, Inc. (NASDAQ: RDNT) is projected to report quarterly earnings at $0.18 per share on revenue of $248.20 million.
  • KNOT Offshore Partners LP (NYSE: KNOP) is estimated to report quarterly earnings at $0.52 per share on revenue of $60.09 million.
  • Smart Sand, Inc. (NASDAQ: SND) is projected to report quarterly earnings at $0.14 per share on revenue of $48.33 million.
  • Ampco-Pittsburgh Corporation (NYSE: AP) is expected to report quarterly loss at $0.42 per share on revenue of $110.00 million.
  • Cannae Holdings, Inc. (NYSE: CNNE) is projected to report quarterly loss at $0.09 per share on revenue of $324.00 million.
  • BioScrip, Inc. (NASDAQ: BIOS) is estimated to report quarterly loss at $0.03 per share on revenue of $188.41 million.
  • Natural Gas Services Group, Inc. (NYSE: NGS) is projected to report quarterly earnings at $0.02 per share on revenue of $17.26 million.

Companies Reporting After The Bell

  • Oracle Corporation (NYSE: ORCL) is projected to post quarterly earnings at $0.84 per share on revenue of $9.61 billion.
  • Adobe Inc. (NASDAQ: ADBE) is expected to post quarterly earnings at $1.61 per share on revenue of $2.55 billion.
  • Jabil Inc. (NYSE:


continue reading





 
 
 

Phil's Favorites

Small brewers show how craft principles could reshape the economy - but they're under threat

 

Small brewers show how craft principles could reshape the economy – but they're under threat

shutterstock.

Courtesy of Maikel Kuijpers, Leiden University; Catalin Popa, Leiden University, and Jochem Kroezen, Cambridge Judge Business School

Our economy currently relies heavily on unsustainable industrial principles of mass scale, never-ending growth and throwaway consu...



more from Ilene

Zero Hedge

Dollar, Bond Yields Plunge As Fed Folds

Courtesy of ZeroHedge. View original post here.

The Fed surprised dovishly and markets are reacting as expected...

The Dollar is getting hammered...

Treasury yields are tumbling - 30Y back below 3.00%...

Following the lower trajectory of The Fed's rate path...

And stocks are bid...

...



more from Tyler

ValueWalk

Feds Last Weapon ... "Empty Words"

By CapitalTrading. Originally published at ValueWalk.

The all-powerful FOMC meets and will provide us with mostly conjecture as to their continued waffle of a monetary policy. It was just a few months ago the FOMC was calling for 4 rate hikes in 2019, my how things have changed, we will be lucky to get one. The combination of balance sheet reduction and lack of global real sustainable growth has led the FOMC to produce nothing short of one’s tail between the legs. Defeated and dejected and spit out of the mouth of the even more powerful global bond markets, who have most certainly called the Fed’s bluff on their rate hikes. What do we mean? Well the yield curves have steepened and 10yr yields have consistently tested ...



more from ValueWalk

Kimble Charting Solutions

Banks Sending Warning Sign To Broad Markets Again?

Courtesy of Chris Kimble.

The financial / banking sector is often a good barometer of the economy and broader stock market.

So when the Bank Index (BKX) began to lag late last summer, it was an early warning sign for investors.

Looking at the chart below, we can see that the banks spilled lower with the December correction. That final swoon lower was set up by a bearish reversal candlestick (1).

Well, the recent rally has brought stocks back up to the scene of that crime! That area is marked by strong horizontal resistance.

Are banks creating a similar reversal ...



more from Kimble C.S.

Insider Scoop

Sage's First-Of-Its-Kind Postpartum Depression Drug Clears FDA Hurdle: What You Need to Know

Courtesy of Benzinga.

Shares of mid-cap biotech SAGE Therapeutics Inc (NASDAQ: SAGE), which focuses on therapies for central nervous system disorders, were trading higher Wednesday.

What Happened

Sage ...



http://www.insidercow.com/ more from Insider

Chart School

RTT browsing latest..

Courtesy of Read the Ticker.

Please review a collection of WWW browsing results. The information here is delayed by a few months, members get the most recent content.



Date Found: Thursday, 20 September 2018, 03:14:19 PM

Click for popup. Clear your browser cache if image is not showing.


Comment: Money rushing into US only stocks IS NEVER A GOOD SIGN, as the informed money now have a uniformed buyer to sell too!



Date Found: Sunday, 23 September 2018, 03:02:29 PM

Click for popup. Clear your browser cache if image is not showing.


Comment: Hedge Fund Legend Ray Dalio On The Economy...



more from Chart School

Biotech

Marijuana is a lot more than just THC - a pharmacologist looks at the untapped healing compounds

Reminder: We are available to chat with Members, comments are found below each post.

 

Marijuana is a lot more than just THC - a pharmacologist looks at the untapped healing compounds

Assorted cannabis bud strains. Roxana Gonzalez/Shutterstock.com

Courtesy of James David Adams, University of Southern California

Medical marijuana is legal in 33 states as of November 2018. Yet the federal government still insists marijuana has no legal u...



more from Biotech

Digital Currencies

Facebook's cryptocurrency: a financial expert breaks it down

 

Facebook's cryptocurrency: a financial expert breaks it down

Grejak/Shutterstock

Courtesy of Alistair Milne, Loughborough University

Facebook is reportedly preparing to launch its own version of Bitcoin, for use in its messaging applications, WhatsApp, Messenger and Instagram. Could this “Facecoin” be the long-awaited breakthrough by a global technology giant into the lucrative market for retail financial services? Or will...



more from Bitcoin

Members' Corner

Despacito - How to Make Money the Old-Fashioned Way - SLOWLY!

Are you ready to retire?  

For most people, the purpose of investing is to build up enough wealth to allow you to retire.  In general, that's usually enough money to reliably generate a year's worth of your average income, each year into your retirement so that that, plus you Social Security, should be enough to pay your bills without having to draw down on your principle.

Unfortunately, as the last decade has shown us, we can't count on bonds to pay us more than 3% and the average return from the stock market over the past 20 years has been erratic - to say the least - with 4 negative years (2000, 2001, 2002 and 2008) and 14 positives, though mostly in the 10% range on the positives.  A string of losses like we had from 2000-02 could easily wipe out a decades worth of gains.

Still, the stock market has been better over the last 10 (7%) an...



more from Our Members

Mapping The Market

It's Not Capitalism, it's Crony Capitalism

A good start from :

It's Not Capitalism, it's Crony Capitalism

Excerpt:

The threat to America is this: we have abandoned our core philosophy. Our first principle of this nation as a meritocracy, a free-market economy, where competition drives economic decision-making. In its place, we have allowed a malignancy to fester, a virulent pus-filled bastardized form of economics so corrosive in nature, so dangerously pestilent, that it presents an extinction-level threat to America – both the actual nation and the “idea” of America.

This all-encompassing mutant corruption saps men’s souls, crushes opportunities, and destroys economic mobility. Its a Smash & Grab system of ill-gotten re...



more from M.T.M.

OpTrader

Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>